Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 42 recruiting now full pipeline

Diabetic Foot Ulcer: full-pipeline trial registry

42 of 68 indexed Diabetic Foot Ulcer trials are currently recruiting.

Corpus placement: #203 of 28,707 conditions by registered trial count.

68 US clinical trials · 42 currently recruiting · #203 of 28,707 conditions by registered trial count

Diabetic Foot Ulcer: 68 US clinical trials tracked, 42 recruiting.

Diabetic Foot Ulcer is the subject of 68 registered US clinical trials on ClinicalTrials.gov, 42 of them currently open to new participants. 9 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Applied Biologics, running 3 of these trials.

Enrollment posture brief

Registry condition diabetic-foot-ulcer

OPEN 42 | RECR 62% | LATE 9 | EARLY 8 | RANK #203 | SPON 3

Nearest open-share peer: Pregnancy, High Risk (62% recruiting · 21 trials)

Diabetic Foot Ulcer (this)62%Brain Metastases60.3%Refractory Multiple Myeloma33.8%Stress Disorders, Post-Traum29.4%Acne Vulgaris2.9%
Open-enrollment share among volume-matched conditions near Diabetic Foot Ulcer

Diabetic Foot Ulcer lists 42 open slots (62% of 68 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetic Foot Ulcer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetic Foot Ulcer is recruiting above its size-band peers.

    42 of 68 indexed trials (61.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Diabetic Foot Ulcer trials is spread across many organizations.

    Applied Biologics accounts for 3 of 68 trials (4.4%). 52 distinct sponsors appear on at least one study for this condition label.

  3. Typical Diabetic Foot Ulcer enrolment sits around 120 participants.

    Median target enrolment is 120 among the 68 trials that report a genuine target (sentinel values excluded). 28 of those (41.2%) plan for fewer than 100 participants.

  4. Diabetic Foot Ulcer research is mostly interventional.

    61 interventional and 7 observational studies make up this index (89.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 26Phase 32Phase 47

Open and recent trials

68 total, page 1 of 2

RECRUITING 5,000 participants

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

University of Michigan

NCT06104969

RECRUITING 700 participants

Non-Invasive Testing to Evaluate Wound Healing in Diabetes

University of Texas Southwestern Medical Center

NCT04232631

RECRUITING Phase 4 650 participants

Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers

BioLab Holdings

NCT07089602

RECRUITING NA 450 participants

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Piomic Medical

NCT05758545

RECRUITING Phase 4 350 participants

Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy

Sequence LifeScience

NCT07086443

RECRUITING NA 350 participants

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Integra LifeSciences Corporation

NCT06453187

RECRUITING Phase 4 340 participants

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

Tiger Biosciences

NCT06826339

RECRUITING NA 324 participants

Modified Multi-Platform Trial Assessing Multiple CAMPs and SOC vs SOC Alone in the Treatment of DFU and VLUs

Stability Biologics

NCT06560502

RECRUITING NA 298 participants

EDX110 Randomized Control Trial for Treatment of DFUs

ConvaTec

NCT07209358

RECRUITING NA 270 participants

Comprehensive Assistance and Resources for Effective Diabetic Foot Navigation

Emory University

NCT07223268

RECRUITING NA 240 participants

Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound Management

Legacy Medical Consultants

NCT06420245

RECRUITING Phase 3 230 participants

A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer

Energenesis Biomedical Co.

NCT05930210

RECRUITING Phase 2 210 participants

Smart Boot Use to Measure Offloading Adherence

University of Southern California

NCT04460573

RECRUITING NA 180 participants

Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC

Surgenex

NCT06515093

RECRUITING NA 180 participants

Real World Evidence with the Debritom+ TM Novel Micro Water Jet Technology At a Single Wound Center

Medaxis

NCT04920253

RECRUITING NA 175 participants

Orthotic Treatment of Diabetic Foot Ulcers

VA Office of Research and Development

NCT05094037

RECRUITING NA 170 participants

Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs

MiMedx Group

NCT06600724

RECRUITING NA 170 participants

Evaluating the Efficacy of Perinatal Membrane Allografts in Addition to the Standard of Care for the Treatment of Non-healing Diabetic Foot Ulcers.

Samaritan Biologics

NCT06437028

RECRUITING NA 170 participants

A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers

Organogenesis

NCT06618612

RECRUITING NA 150 participants

Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Capsicure

NCT06455475

RECRUITING NA 150 participants

Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

Capsicure

NCT06572839

RECRUITING NA 132 participants

Evaluating the Efficacy NeoThelium FT in the Treatment of Diabetic Foot Ulcers

NuScience Medical Biologics

NCT06938685

RECRUITING NA 130 participants

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

Omeza

NCT07161830

RECRUITING NA 124 participants

Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care Versus Standard of Care

Applied Biologics

NCT06564831

RECRUITING NA 120 participants

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

Johns Hopkins University

NCT05579743

RECRUITING Phase 4 120 participants

Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)

Cellution Biologics

NCT07014176

RECRUITING NA 100 participants

Total Contact Soft Cast in Diabetic Foot Ulcers

University of Minnesota

NCT04210089

RECRUITING NA 100 participants

Dehydrated Human Amnion Membrane and Standard of Care Versus Standard of Care Alone in Nonhealing Diabetic Foot Ulcers

Axolotl Biologix

NCT06550596

RECRUITING NA 69 participants

Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

Johns Hopkins University

NCT04164641

RECRUITING NA 68 participants

A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.

Molnlycke Health Care AB

NCT05588583

RECRUITING Phase 4 60 participants

A Multicenter, Prospective, Controlled Clinical Trial Evaluating the Efficacy of a Single Layer Placental-based Allograft and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers

Applied Biologics

NCT07159282

RECRUITING NA 60 participants

Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers

University of New Mexi

NCT04791449

RECRUITING NA 60 participants

Evaluating a Lifestyle Intervention to Prevent Recurrence of Diabetic Foot Ulcers

University of Southern California

NCT06487780

RECRUITING Phase 2 60 participants

A Phase 2a Proof of Concept Open-Label, Randomized, Controlled Study to Evaluate the Safety and Efficacy of MDI-1228-mesylate Gel Compared With Standard of Care Alone in Patients With Diabetic Foot Ulcers

Zhuhai Rui-Inno Pharmaceutical Technology Co.

NCT06852976

RECRUITING 50 participants

Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.

Applied Biologics

NCT07360418

RECRUITING Phase 4 50 participants

A Multicenter, Prospective, Controlled Modified Multi-Platform Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers.

BioLab Holdings

NCT07364630

RECRUITING Phase 1 40 participants

NOX1416 in Treatment of Chronic Non-Healing Diabetic Foot Ulcers

NOxy Health Products

NCT06402565

RECRUITING Phase 2 30 participants

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

Estar Medical dba Medical Technologies

NCT06810726

RECRUITING NA 20 participants

Adapting Lifestyle Offloading for DFUs

University of Southern California

NCT06278935

RECRUITING 20 participants

Mirragen Diabetic Foot Ulcer Study

The University of Texas Health Science Center at San Antonio

NCT06598241

RECRUITING Phase 1 15 participants

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

Eluciderm

NCT07396376

RECRUITING NA 10 participants

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Diabetic Foot Ulcers

NuScience Medical Biologics

NCT07039396

ACTIVE NOT RECRUITING 2,500 participants

Geko™ Cross Therapy Registry - Wound

Firstkind

NCT05007301

ACTIVE NOT RECRUITING Phase 4 292 participants

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

Cellution Biologics

NCT06562296

ACTIVE NOT RECRUITING NA 222 participants

A Unique Micro Water Jet Technology Device Versus Standard Debridement in the Treatment of Diabetic Foot

Medaxis

NCT04564443

ACTIVE NOT RECRUITING NA 100 participants

Efficacy of ProgenaMatrix™ in the Management of DFUs

ProgenaCare Global

NCT06292026

ACTIVE NOT RECRUITING NA 100 participants

Omega3 Wound Fish Skin Graft in the Treatment of DFUs

Kerecis

NCT04133493

ACTIVE NOT RECRUITING NA 72 participants

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

BioStem Technologies

NCT06565156

ACTIVE NOT RECRUITING NA 30 participants

Sterilised, Porcine Placental Tissue in the Treatment of Chronic Diabetic Foot Ulcers

ConvaTec

NCT05687656

COMPLETED 400 participants

Wound Assessment Using Spectral Imaging US

SpectralMD

NCT05415683

Page 1 of 2 Next →

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 6
Phase 3 2
Phase 4 7

Named interventions

Most-linked intervention names on Diabetic Foot Ulcer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Standard of Care Other
7 trials
Standard of care Other
3 trials
Membrane Wrap-Hydro™ DFU Other
2 trials
Membrane Wrap-Lite™ DFU Other
2 trials
Membrane Wrap™ DFU Other
2 trials
Tri-Membrane Wrap™ DFU Other
2 trials
Standard of Care Procedure
2 trials
Standard of Care (SOC) Procedure
2 trials

US sites by state

Facility locations filed on Diabetic Foot Ulcer trials. A trial with sites in several states counts in each.

California 25 trials
Florida 22 trials
Texas 18 trials
Pennsylvania 18 trials
Ohio 9 trials
Illinois 9 trials
Virginia 8 trials
New York 8 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetic Foot Ulcer page

68 registered trials, 42 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 42 Diabetic Foot Ulcer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Applied Biologics sponsors the most Diabetic Foot Ulcer trials on record, review their full trial history before evaluating a specific study. See Applied Biologics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Foot Ulcer condition card totals 68 registered trials; most-linked intervention Standard of Care; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.